Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2015 / Feb / Targeting Heritable Childhood Blindness
Neuro-ophthalmology Research & Innovations

Targeting Heritable Childhood Blindness

Gene sequencing study identifies a gene mutation responsible for heritable cases of LCA and OMS for the first time

By Mark Hillen 2/10/2015 1 min read

Share

0215-206-main

Researchers who performed a whole exome gene sequencing study on seven families with inherited retinal degeneration have identified a new gene that is thought to be responsible for some cases of Leber Congenital Amaurosis (LCA) and Oliver-McFarlane Syndrome (OMS): PNPLA6 (1). The gene is the first to be associated with OMS, and codes for the enzyme neuropathy target esterase (NTE) – a phospholipase that is thought to play a role in embryonic neurite outgrowth and process elongation during neuronal differentiation.

In order to determine NTE’s role in the retina, the study authors established that NTE is expressed in photoreceptors of both Drosophila and mice by immunihistochemistry, and that knocking out PNPLA6 in Drosophila results in photoreceptor neuron death. PNPLA6-/- mouse embryos fail to develop past E8.5, but the study authors hope to generate and characterize a photoreceptor-specific PNPLA6-/- knockout mouse in the future. They suggest that “NTE is essential for vision and photoreceptor biology”, and that “mutations in PNPLA6 cause photoreceptor neuron death and blindness in children with OMS and LCA” (1).

References

  1. S. Kmoch et al., “Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness”, Nat Commun., Epub ahead of print, (2015). PMID: 25574898.

About the Author(s)

Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

More Articles by Mark Hillen

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: